A 32-year-old man developed gastroparesis after taking tirzepatide for weight loss, which isn't approved in India. Doctors ...

Semaglutide was one of 15 drugs the CMS selected ... very clear that when a drug is selected for negotiation, all dosage forms and strengths with the same active ingredients are included, even ...

Ozempic may help reduce alcohol cravings, according to a new study. But you shouldn't use them to help curb drinking habits ...

Novo’s booming semaglutide franchise for diabetes and ... ingredient together for negotiation regardless of their dosage forms or indications. This practice is now reflected in the inclusion ...

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Wegovy, a medication that contains the same main ingredient as Ozempic, semaglutide ... use data that is aggregated across different dosage, forms and strengths of a drug in the negotiation ...

After Semaglutide, Tirzepatide is probably the next best known GLP-1 agonist. It is sold in two forms - Mounjaro and Zepbound - by United States (US) pharmaceutical company Eli Lilly. Both products ...

NAD as an injectable has been around for awhile, but bringing it to patients homes and expanding for those who do not like giving themselves injections to the additional dosage forms allows ...